Abstract
Behçet’s disease (BD) is a chronic inflammatory disease of unknown origin, featuring recurrent aphthous ulcers in the oral mucosa, uveitis, skin symptoms, and vulvar ulcers. Its inflammation can involve important organs such as the gastrointestinal tract, central nervous system, and vascular system. BD with gastrointestinal lesions is called intestinal BD, which is more common in Japan and Korea than elsewhere. Although ulcers at the ileocecal site are representative of intestinal BD, any part of the gastrointestinal tract can be involved. Therefore, the symptoms of intestinal BD are diverse and nonspecific. There are no specific markers for diagnosing this condition, and establishing the diagnosis of intestinal BD still remains a challenge. In the differential diagnosis of intestinal BD, Crohn’s disease and intestinal tuberculosis often need to be ruled out. Glucocorticoids and antitumor necrosis factor-α antibodies are the key agents for the treatment of intestinal BD. Many patients experience disease flare-up, and they sometimes follow a severe clinical course.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Skef W, Hamilton MJ, Arayssi T. Gastrointestinal Behcet’s disease: a review. World J Gastroenterol. 2015;21(13):3801–12.
Sakane T, Takeno M, Suzuki N, Inaba G. Behcet’s disease. N Engl J Med. 1999;341(17):1284–91.
Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR. Behcet’s disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens. 1999;54(3):213–20.
Alpsoy E. Behcet’s disease: a comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions. J Dermatol. 2016;43(6):620–32.
Takeuchi M, Kastner DL, Remmers EF. The immunogenetics of Behcet’s disease: a comprehensive review. J Autoimmun. 2015;64:137–48.
Mahr A, Belarbi L, Wechsler B, et al. Population-based prevalence study of Behcet’s disease: differences by ethnic origin and low variation by age at immigration. Arthritis Rheum. 2008;58(12):3951–9.
Alpsoy E, Donmez L, Onder M, et al. Clinical features and natural course of Behcet’s disease in 661 cases: a multicentre study. Br J Dermatol. 2007;157(5):901–6.
Balta I, Akbay G, Kalkan G, Eksioglu M. Demographic and clinical features of 521 Turkish patients with Behcet’s disease. Int J Dermatol. 2014;53(5):564–9.
Ideguchi H, Suda A, Takeno M, Ueda A, Ohno S, Ishigatsubo Y. Behcet disease: evolution of clinical manifestations. Medicine (Baltimore). 2011;90(2):125–32.
Gul A, Ohno S. HLA-B*51 and Behcet disease. Ocul Immunol Inflamm. 2012;20(1):37–43.
Mizuki N, Meguro A, Ota M, et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet’s disease susceptibility loci. Nat Genet. 2010;42(8):703–6.
Remmers EF, Cosan F, Kirino Y, et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet’s disease. Nat Genet. 2010;42(8):698–702.
Kirino Y, Bertsias G, Ishigatsubo Y, et al. Genome-wide association analysis identifies new susceptibility loci for Behcet’s disease and epistasis between HLA-B*51 and ERAP1. Nat Genet. 2013;45(2):202–7.
Tasliyurt T, Yigit S, Rustemoglu A, Gul U, Ates O. Common MEFV gene mutations in Turkish patients with Behcet’s disease. Gene. 2013;530(1):100–3.
Kirino Y, Zhou Q, Ishigatsubo Y, et al. Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behcet disease. Proc Natl Acad Sci U S A. 2013;110(20):8134–9.
Zhou Q, Wang H, Schwartz DM, et al. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. Nat Genet. 2016;48(1):67–73.
Akman A, Kacaroglu H, Donmez L, Bacanli A, Alpsoy E. Relationship between periodontal findings and Behcet’s disease: a controlled study. J Clin Periodontol. 2007;34(6):485–91.
Hirohata S, Oka H, Mizushima Y. Streptococcal-related antigens stimulate production of IL6 and interferon-gamma by T cells from patients with Behcet’s disease. Cell Immunol. 1992;140(2):410–9.
Neves FS, Spiller F. Possible mechanisms of neutrophil activation in Behcet’s disease. Int Immunopharmacol. 2013;17(4):1206–10.
Hamzaoui K, Hamzaoui A, Hentati F, et al. Phenotype and functional profile of T cells expressing gamma delta receptor from patients with active Behcet’s disease. J Rheumatol. 1994;21(12):2301–6.
Leng RX, Chen GM, Pan HF, Ye DQ. The role of IL-23/IL-17 axis in the etiopathogenesis of Behcet’s disease. Clin Rheumatol. 2010;29(10):1209.
Ben Ahmed M, Houman H, Miled M, Dellagi K, Louzir H. Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behcet’s disease. Arthritis Rheum. 2004;50(7):2291–5.
Grigg EL, Kane S, Katz S. Mimicry and deception in inflammatory bowel disease and intestinal Behcet disease. Gastroenterol Hepatol (N Y). 2012;8(2):103–12.
Bayraktar Y, Ozaslan E, Van Thiel DH. Gastrointestinal manifestations of Behcet’s disease. J Clin Gastroenterol. 2000;30(2):144–54.
Yi SW, Cheon JH, Kim JH, et al. The prevalence and clinical characteristics of esophageal involvement in patients with Behcet’s disease: a single center experience in Korea. J Korean Med Sci. 2009;24(1):52–6.
Houman MH, Ben Ghorbel I, Lamloum M, et al. Esophageal involvement in Behcet’s disease. Yonsei Med J. 2002;43(4):457–60.
Oose T, Tokutomi K, Takeuchi A, Hashimoto T. [A case of Behcet’s disease with severe esophageal stenosis treated with esophageal bujie]. Ryumachi. 1995;35(1):81–4.
Morimoto Y, Tanaka Y, Itoh T, Yamamoto S, Kurihara Y, Nishikawa K. Esophagobronchial fistula in a patient with Behcet’s disease: report of a case. Surg Today. 2005;35(8):671–6.
Powderly WG, Lombard MG, Murray FE, O’Connell D, Counihan TB, Lennon JR. Oesophageal ulceration in Behcet’s disease presenting with haemorrhage. Ir J Med Sci. 1987;156(6):193–4.
Bektas M, Altan M, Alkan M, Ormeci N, Soykan I. Manometric evaluation of the esophagus in patients with Behcet’s disease. Digestion. 2007;76(3–4):192–5.
Ning-Sheng L, Ruay-Sheng L, Kuo-Chih T. High frequency of unusual gastric/duodenal ulcers in patients with Behcet’s disease in Taiwan: a possible correlation of MHC molecules with the development of gastric/duodenal ulcers. Clin Rheumatol. 2005;24(5):516–20.
Arendt T, Kloehn S, Bastian A, et al. A case of Behcet’s syndrome presenting with Dieulafoy’s ulcer. Z Gastroenterol. 1997;35(10):935–8.
Abe T, Yachi A, Yabana T, et al. Gastric non-Hodgkin’s lymphoma associated with Behcet’s disease. Intern Med. 1993;32(8):663–7.
Ozenc A, Bayraktar Y, Baykal A. Pyloric stenosis with esophageal involvement in Behcet’s syndrome. Am J Gastroenterol. 1990;85(6):727–8.
Behcet BR. Disease associated with severe gastroparesis: a dramatic response to combination therapy with methotrexate and infliximab. Arthritis Rheum. 2001;44(9 Suppl):S40–520.
Avci O, Ellidokuz E, Simsek I, Buyukgebiz B, Gunes AT. Helicobacter pylori and Behcet’s disease. Dermatology. 1999;199(2):140–3.
Hamdulay SS, Cheent K, Ghosh C, Stocks J, Ghosh S, Haskard DO. Wireless capsule endoscopy in the investigation of intestinal Behcet’s syndrome. Rheumatology (Oxford). 2008;47(8):1231–4.
Neves FS, Fylyk SN, Lage LV, et al. Behcet’s disease: clinical value of the video capsule endoscopy for small intestine examination. Rheumatol Int. 2009;29(5):601–3.
Lee CR, Kim WH, Cho YS, et al. Colonoscopic findings in intestinal Behcet’s disease. Inflamm Bowel Dis. 2001;7(3):243–9.
Le Thi Huong D, Wechsler B, Dell’Isola B, et al. Acute pancreatitis in Behcet’s disease. Dig Dis Sci. 1992;37(9):1452–3.
Backmund M, Schomerus P. Acute pancreatitis and pericardial effusion in Behcet’s disease. Gastroenterology. 1999;117(1):286.
Lakhanpal S, Tani K, Lie JT, Katoh K, Ishigatsubo Y, Ohokubo T. Pathologic features of Behcet’s syndrome: a review of Japanese autopsy registry data. Hum Pathol. 1985;16(8):790–5.
Chawla S, Atten MJ, Attar BM. Acute pancreatitis as a rare initial manifestation of Wegener’s granulomatosis. A case based review of literature. JOP. 2011;12(2):167–9.
Kuniyoshi Y, Koja K, Miyagi K, et al. Surgical treatment of Budd-Chiari syndrome induced by Behcet’s disease. Ann Thorac Cardiovasc Surg. 2002;8(6):374–80.
Ben Ghorbel I, Ennaifer R, Lamloum M, Khanfir M, Miled M, Houman MH. Budd-Chiari syndrome associated with Behcet’s disease. Gastroenterol Clin Biol. 2008;32(3):316–20.
Bayraktar Y, Balkanci F, Bayraktar M, Calguneri M. Budd-Chiari syndrome: a common complication of Behcet’s disease. Am J Gastroenterol. 1997;92(5):858–62.
Korkmaz C, Kasifoglu T, Kebapci M. Budd-Chiari syndrome in the course of Behcet’s disease: clinical and laboratory analysis of four cases. Joint Bone Spine. 2007;74(3):245–8.
Calamia KT, Schirmer M, Melikoglu M. Major vessel involvement in Behcet’s disease: an update. Curr Opin Rheumatol. 2011;23(1):24–31.
Manna R, Ghirlanda G, Bochicchio GB, et al. Chronic active hepatitis and Behcet’s syndrome. Clin Rheumatol. 1985;4(1):93–6.
Orloff LA, Orloff MJ. Budd-Chiari syndrome caused by Behcet’s disease: treatment by side-to-side portacaval shunt. J Am Coll Surg. 1999;188(4):396–407.
Sato S, Yashiro M, Matsuoka N, et al. Behcet disease associated with gastrointestinal amyloidosis manifested as hematochezia: a case report. Medicine (Baltimore). 2018;97(26):e11153.
Criteria for diagnosis of Behcet’s disease. International Study Group for Behcet’s Disease. Lancet. 1990;335(8697):1078–80.
International Team for the Revision of the International Criteria for Behçet’s Disease (ITR-ICBD). The International Criteria for Behcet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28(3):338–47.
Mizushima Y. Recent research into Behcet’s disease in Japan. Int J Tissue React. 1988;10(2):59–65.
Cheon JH, Kim ES, Shin SJ, et al. Development and validation of novel diagnostic criteria for intestinal Behcet’s disease in Korean patients with ileocolonic ulcers. Am J Gastroenterol. 2009;104(10):2492–9.
Lee SK, Kim BK, Kim TI, Kim WH. Differential diagnosis of intestinal Behcet’s disease and Crohn’s disease by colonoscopic findings. Endoscopy. 2009;41(1):9–16.
Ng SC, Hirai HW, Tsoi KK, et al. Systematic review with meta-analysis: accuracy of interferon-gamma releasing assay and anti-Saccharomyces cerevisiae antibody in differentiating intestinal tuberculosis from Crohn’s disease in Asians. J Gastroenterol Hepatol. 2014;29(9):1664–70.
Cheon JH, Kim WH. An update on the diagnosis, treatment, and prognosis of intestinal Behcet’s disease. Curr Opin Rheumatol. 2015;27(1):24–31.
Jung YS, Cheon JH, Park SJ, Hong SP, Kim TI, Kim WH. Long-term clinical outcomes of Crohn’s disease and intestinal Behcet’s disease. Inflamm Bowel Dis. 2013;19(1):99–105.
Yazisiz V. Similarities and differences between Behcet’s disease and Crohn’s disease. World J Gastrointest Pathophysiol. 2014;5(3):228–38.
Papp M, Norman GL, Altorjay I, Lakatos PL. Utility of serological markers in inflammatory bowel diseases: gadget or magic? World J Gastroenterol. 2007;13(14):2028–36.
Hatemi G, Silman A, Bang D, et al. Management of Behcet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behcet disease. Ann Rheum Dis. 2009;68(10):1528–34.
Cheon JC, Celik AF, Kim WH. Behçet’s disease: gastrointestinal involvement. In: Yazici Y, Yazici H, editors. Behçet’s syndrome. 1st ed. New York: Springer; 2010. p. 165–88.
Hisamatsu T, Ueno F, Matsumoto T, et al. The 2nd edition of consensus statements for the diagnosis and management of intestinal Behcet’s disease: indication of anti-TNFalpha monoclonal antibodies. J Gastroenterol. 2014;49(1):156–62.
Saleh Z, Arayssi T. Update on the therapy of Behcet disease. Ther Adv Chronic Dis. 2014;5(3):112–34.
Travis SP, Czajkowski M, McGovern DP, Watson RG, Bell AL. Treatment of intestinal Behcet’s syndrome with chimeric tumour necrosis factor alpha antibody. Gut. 2001;49(5):725–8.
Hassard PV, Binder SW, Nelson V, Vasiliauskas EA. Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behcet’s disease: a case report. Gastroenterology. 2001;120(4):995–9.
Kinoshita H, Kunisaki R, Yamamoto H, et al. Efficacy of infliximab in patients with intestinal Behcet’s disease refractory to conventional medication. Intern Med. 2013;52(17):1855–62.
Bawazeer A, Raffa LH, Nizamuddin SH. Clinical experience with adalimumab in the treatment of ocular Behcet disease. Ocul Immunol Inflamm. 2010;18(3):226–32.
Tanida S, Inoue N, Kobayashi K, et al. Adalimumab for the treatment of Japanese patients with intestinal Behcet’s disease. Clin Gastroenterol Hepatol. 2015;13(5):940–948.e943.
Ariyachaipanich A, Berkelhammer C, Nicola H. Intestinal Behcet’s disease: maintenance of remission with adalimumab monotherapy. Inflamm Bowel Dis. 2009;15(12):1769–71.
Jung YS, Yoon JY, Lee JH, et al. Prognostic factors and long-term clinical outcomes for surgical patients with intestinal Behcet’s disease. Inflamm Bowel Dis. 2011;17(7):1594–602.
Jung YS, Yoon JY, Hong SP, Kim TI, Kim WH, Cheon JH. Influence of age at diagnosis and sex on clinical course and long-term prognosis of intestinal Behcet’s disease. Inflamm Bowel Dis. 2012;18(6):1064–71.
Park JJ, Kim WH, Cheon JH. Outcome predictors for intestinal Behcet’s disease. Yonsei Med J. 2013;54(5):1084–90.
Saadoun D, Wechsler B, Desseaux K, et al. Mortality in Behcet’s disease. Arthritis Rheum. 2010;62(9):2806–12.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Asano, T., Sato, S., Migita, K. (2019). Gastrointestinal Involvement of Behçet’s Disease. In: Ohira, H., Migita, K. (eds) Gastrointestinal and Hepatic Manifestations of Rheumatic Diseases. Springer, Singapore. https://doi.org/10.1007/978-981-13-6524-9_10
Download citation
DOI: https://doi.org/10.1007/978-981-13-6524-9_10
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-6523-2
Online ISBN: 978-981-13-6524-9
eBook Packages: MedicineMedicine (R0)